-

Global Continuous Glucose Monitoring Devices Market Report 2023: An $11.2 Billion Market by 2030 Featuring Medtronic, Dexom, F. Hoffmann-La Roche, Abbott, Ypsomed, GlySens, & Ascensia Diabetes Care - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Receivers), By End-use (Hospitals, Home Care), By Connectivity, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global continuous glucose monitoring devices market size is expected to reach USD 11.2 billion by 2030, registering a CAGR of 4.4% from 2023 to 2030

The two primary factors propelling the market expansion are the rise in diabetes incidences and the launch of technologically advanced diabetes care devices. Continuous glucose monitoring (CGM) devices are effective to evaluate body glucose levels in real-time. These devices transmit the data they collect across a wireless network to receivers, which aids in tracking the levels of glucose during a certain time.

While lowering individual insulin dosages, these devices also assist in managing diabetes. These devices' built-in software gives users access to information on food consumption, medicine use, physical activity, and illnesses. As a result, a growing number of diabetic patients are employing these devices to control and treat their condition, which is fueling market expansion.

A growing number of continuous glucose monitoring devices are being integrated with apps and software to assist patients with diabetes mellitus as a result of the development of digital treatments. Apps such as Glucose buddy, Diabetes Connect, My Sugar, and others are available under a paid subscription.

Furthermore, the rise in the number of diabetes mellitus has contributed significantly toward the CGM systems market growth. The device allows real-time biofeedback and behavioral change support, allowing effective management of diabetes by the patient. Additionally, the government is spending a huge amount on diabetic care tools to closely monitor diabetes in patients.

For instance, according to the International Diabetes Federation, 32.2 million Americans lived with diabetes in 2021. The same source stated that diabetes-related healthcare expenditure was about 11,779.2 USD per person in the U.S., which is expected to increase to 12,184.8 USD by 2045. Such, initiatives are said to influence market growth.

Continuous Glucose Monitoring Devices Market Report Highlights

  • By component, the sensors segment held a major share of the global market in 2022, owing to the integral nature of these devices
  • By end-use, the home care segment dominated the market in 2022, owing to favorable reimbursement and higher adoption especially due to the outbreak of the COVID-19 pandemic, and the rise in virtual care
  • The Bluetooth segment held the larger share of 56.3% in the connectivity segment, due to the need for the replacement of Bluetooth-enabled sensors and the cost associated with its manufacturing
  • North America dominated the market in 2022, attributed to the wide usage of CGM devices as a result of a higher number of target patients in the region
  • Europe followed North America closely in terms of market revenue due to a rise in the adoption of these devices in key countries

Market Dynamics

Market Driver Analysis

  • Increasing prevalence of diabetes globally
  • Technological advancements
  • Favorable reimbursement scenario

Market Restraint Analysis

  • High cost and low awareness

Continuous Glucose Monitoring Devices: Market Analysis Tools

  • Industry Analysis - Porter's
  • PESTEL Analysis
  • Major Deals & Strategic Alliances Analysis

Competitive Analysis

  • Medtronic
  • Dexom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Ypsomed
  • GlySens, Inc.
  • Ascensia Diabetes Care

For more information about this report visit https://www.researchandmarkets.com/r/qmhz7g

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th - Mar 26th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries....

European Union Veterinary Pharmacovigilance Introductory Training Course: Practical Guidance and Basic Training for All Those Working in Drug Safety (Mar 9th - Mar 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to Veterinary Pharmacovigilance Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day event has been designed to provide an essential overview of veterinary pharmacovigilance and will offer practical guidance and basic training for all those working in drug safety in the EU. Our experienced trainer will clarify roles and responsibilities, explain commonly used terminology and take partici...

Pharma and Medical Device Clinical Quality Management Systems Training Course: EMA Guidance on Computerised Systems and ICH GCP R3 Data Governance (Mar 23rd - Mar 24th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Quality Management Systems Training Course (Mar 23rd - Mar 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will provide essential information and guidance to help you achieve regulatory compliance in this evolving area of clinical quality, including EMA guidance on computerised systems and ICH GCP R3 data governance. With increasing clinical quality standards required by inspectors, there is currently no harmonised re...
Back to Newsroom